41. A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta. (27th September 2022) Authors: Mavroudis, Panteleimon D.; Pillai, Nikhil; Wang, Qingping; Pouzin, Clemence; Greene, Benjamin; Fretland, Jennifer Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 11(2022) Page Start: 1485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. A Network Pharmacology Approach for the Identification of Common Mechanisms of Drug‐Induced Peripheral Neuropathy. (20th February 2019) Authors: de Anda‐Jáuregui, Guillermo; McGregor, Brett A.; Guo, Kai; Hur, Junguk Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 4(2019) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose–Response Curve. (19th February 2015) Authors: Goswami, C Pankaj; Cheng, L; Alexander, PS; Singal, A; Li, L Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 2(2015:Feb.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose–Response Curve. (19th February 2015) Authors: Goswami, C Pankaj; Cheng, L; Alexander, PS; Singal, A; Li, L Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 2(2015:Feb.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. A New Method to Model and Predict Progression Free Survival Based on Tumor Growth Dynamics. (12th March 2020) Authors: Yu, Jiajie; Wang, Nina; Kågedal, Matts Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 3(2020) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. A Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3‐O‐glucuronide in Renal or Hepatic Impairment. (8th May 2013) Authors: van der Walt, J‐S; Hong, Y; Zhang, L; Pfister, M; Boulton, DW; Karlsson, MO Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 5(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. A novel cardiovascular systems model to quantify drugs effects on the inter‐relationship between contractility and other hemodynamic variables. (18th March 2022) Authors: Fu, Yu; Taghvafard, Hadi; Said, Medhat M.; Rossman, Eric I.; Collins, Teresa A.; Billiald‐Desquand, Stéphanie; Leishman, Derek; van der Graaf, Piet H.; van Hasselt, J. G. Coen; Snelder, Nelleke Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 5(2022) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist. (24th December 2021) Authors: Bosch, Rolien; Petrone, Marcella; Arends, Rosalin; Vicini, Paolo; Sijbrands, Eric J. G.; Hoefman, Sven; Snelder, Nelleke Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 3(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach. (5th May 2021) Authors: Ayral, Géraldine; Si Abdallah, Jean‐François; Magnard, Claude; Chauvin, Jonathan Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 4(2021) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug‐Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide. (31st October 2018) Authors: Lüpfert, Christian; Dyroff, Martin; von Richter, Oliver; Gallemann, Dieter; El Bawab, Samer; Dolgos, Hugues; Jung, Don; Hecht, Stefan; Johne, Andreas Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 12(2018) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗